Fed Tightening Will Unleash U.S. Growth

Lior Alkalay - INO.com Contributor - Forex


The Federal Reserve, the only central bank in the G7 economies and China to raise rates and the only central bank to lead a tightening cycle, is also the only central bank to get it right. As counter-intuitive as that may sound, higher rates in a world of negative rates and massive monetization is the only viable solution to stimulate growth. To understand the irony, we must delve into credit markets and assess what’s broken.

Cheap Credit Expensive Growth

One of the arguments espoused by critics of monetary stimulus, whether it’s negative interest rates or quantitative easing, is inflation. But in reality the real cost of a ultra-loose monetary policy is the exact opposite—deflation; prices in most of the world and, in fact, in most products are either falling or stagnating. The reason is that when the policy is ultra-loose inefficient sectors of the economy are kept artificially afloat. As long as interest rates are close to zero failing sectors can keep on piling debt and thus contribute less and less to growth while leaving less available capital to the more efficient sectors that really need to grow. Continue reading "Fed Tightening Will Unleash U.S. Growth"

McKesson Pressured Over Drug Pricing Concerns

Noah Kiedrowski - INO.com Contributor - Biotech


Introduction

McKesson Corporation (NYSE:MCK) along with other pharmaceutical distribution companies such as Cardinal Health and AmerisourceBergen have been under tremendous pressure as of late due to political pressures regarding the pharmaceutical supply chain and drug pricing concerns. I recently wrote an article “McKesson Jumps 34% Off Lows – Now What” stating that the easy money had been made from the ~$150 level to the roughly ~$200 level. I also pointed out that greater than 98% of McKesson’s revenues come from pharmaceutical distribution and services domestically and abroad. Thus any impact to this business model will likely have direct negative implications with regard to revenues and EPS. At the closing of that article I stated that currently, McKesson’s P/E ratio sits at the top of its peer cohort and considering the stock has risen over 34% along with the potential erosion of the middle model, I’d be cautious buying at these levels despite additional upside based on its 52-week high of $240. Now enter the latest EpiPen fiasco and subsequent drug price scrutiny being thrusted into the spotlight. Due to a Tweet by Hillary Clinton regarding her distain for Mylan’s price increase, McKesson saw a $7 per share drop or roughly 4% drop in that same session. Since any disruption in this business model will negatively impact McKesson disproportionally compared to the insurance, pharmacy and pharmacy benefit manager (PBM) companies, I’d avoid McKesson especially after the ~30% move to the upside.

McKesson - Pharmaceutical Supply Chain Complexities

The interplay within pharmaceutical supply chain players can be a challenging dynamic to grasp. McKesson positions itself on the distribution side of the network, essentially serving as an intermediary between the drug manufacturer and the pharmacy. McKesson and other middlemen such as Cardinal Health and AmerisourceBergen purchase drugs directly from the manufacturer and then sell them to the pharmacy and capture the spread between the price they pay (to the drug marker) and the price they sell (to the pharmacy) the drugs. Below is a step-by-step breakdown of the pharmaceutical supply chain steps (Figure 1): Continue reading "McKesson Pressured Over Drug Pricing Concerns"

3 ETFs 20 Somethings Should Buy

Matt Thalman - INO.com Contributor - ETFs


There has never been a better time to be an investor. No Matter your age, investing experience, investing temperament or income level, there are a number of investment options that are right for you. I recently wrote a piece discussing a few of my favorite Exchange Traded Funds geared for all investors. Most investors should buy a few of the ETFs I mentioned in the piece or ETFs similar in nature and be set. But, after writing that piece, I began to think about how different age groups have different interests and different goals with their money and may want to further diversify their holdings based on their personal preferences.

So with that in mind, today we will be talking about three ETFs that investors in their 20's would be interested in. But before we get any further, everyone should remember the ETFs mentioned in the previous piece should still make-up a portion of your investment able assets, simply due to their stability and diversity. Continue reading "3 ETFs 20 Somethings Should Buy"

How The Natural Gas Storage Glut Has Been Cut This Summer

Robert Boslego - INO.com Contributor - Energies


The National Oceanic and Atmospheric Administration (NOAA) reports cooling degree day (CDD) data for every seven-day period by state. From that data, they construct a populated-weighted national total.

CDDs are the difference between the daily temperature mean (high temperature plus low temperature divided by two) and 65°F. If the temperature mean is above 65°F, we subtract 65 from the mean.

Example: The high temperature for a particular day was 90°F and the low temperature was 66°F. The temperature mean for that day was: Continue reading "How The Natural Gas Storage Glut Has Been Cut This Summer"

Let's Read The Coffee Grounds To Understand Gold

Aibek Burabayev - INO.com Contributor - Metals


Sometimes we find a revelation in different things or places. Extending the range of our focus is quite helpful. From time to time I watch stock charts to find some interesting setups and to let my eyesight get a refreshing break from commodities and forex.

Last night I was browsing through some stock charts and my eyes caught a familiar structure on one of them. It was a chart of the iPath Bloomberg Coffee Subindex Total Return ETN (NYSE:JO). This instrument has a very interesting structure of complex correction on the chart. And today I would like to share with you an educational chart with a sample of a complex correction, which could take place in gold. It is better so see it once than to hear about it many times. Continue reading "Let's Read The Coffee Grounds To Understand Gold"